Finance

Lists
603351:SHA
Nanjing Well Pharmaceutical Group Co Ltd
CN¥26.64
-1.52%
(-0.41) 1D
Oct 30, 3:00:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603351...
Open
CN¥26.80
High
CN¥27.78
Low
CN¥26.35
Mkt. cap
3.61B
Avg. vol.
2.07M
Volume
1.97M
Dividend
2.25%
Quarterly dividend
CN¥0.15
Ex-dividend date
Jun 5, 2026
P/E ratio
22.99
52-wk high
CN¥30.80
52-wk low
CN¥21.90
EPS
CN¥1.16
No. of employees
718
Open
CN¥26.80
High
CN¥27.78
Low
CN¥26.35
Mkt. cap
3.61B
Avg. vol.
2.07M
Volume
1.97M
Dividend
2.25%
Quarterly dividend
CN¥0.15
Ex-dividend date
Jun 5, 2026
P/E ratio
22.99
52-wk high
CN¥30.80
52-wk low
CN¥21.90
EPS
CN¥1.16
No. of employees
718
News stories
From web sources and news partners
About Nanjing Well Pharmaceutical Group Co Ltd
CEO-
Employees718
FoundedFeb 18, 2000
Headquarters-
SectorCommodity chemical
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
316.80M
356.30M
383.29M
342.15M
Cost of goods sold
232.82M
258.38M
279.80M
241.71M
Cost of revenue
232.82M
258.38M
279.80M
241.71M
Research and development expenses
20.55M
19.09M
21.08M
19.87M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
25.44M
27.73M
33.67M
26.75M
Operating expense
47.14M
48.21M
55.06M
45.71M
Total operating expenses
279.96M
306.58M
334.86M
287.42M
Operating income
36.83M
49.72M
48.43M
54.73M
Other non operating income
220.72K
-2.06M
1.94M
-8.28M
EBT including unusual items
39.07M
43.92M
46.03M
50.58M
EBT excluding unusual items
33.62M
43.93M
45.70M
54.84M
Income tax expense
1.82M
7.07M
7.36M
7.82M
Effective tax rate
4.65%
16.11%
15.98%
15.46%
Other operating expenses
1.06M
506.84K
372.91K
-99.51K
Net income
36.90M
37.63M
39.15M
43.26M
Net profit margin
11.65%
10.56%
10.21%
12.64%
Earnings per share
-
-
-
-
Interest and investment income
85.57K
113.84K
360.14K
6.41M
Interest expense
-2.32M
-3.85M
-2.56M
-473.97K
Net interest expenses
-2.23M
-3.73M
-2.20M
5.93M
Depreciation and amortization charges
-
-
-
-
EBITDA
67.52M
80.41M
79.05M
85.41M
Gain or loss from assets sale
-16.25K
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps